Akbar Seddigh
Chairman at Blekinge Tekniska Högskola
Profile
Akbar Seddigh is currently the Chairman at Blekinge Tekniska Högskola.
Previously, he served as the Chairman at Elekta AB from 1998 to 2013.
He also held Chairman positions at A+ Science Holding AB, Hedson Technologies International AB, and Innovationsbron AB.
Additionally, he served as a Director at Light Sciences Oncology, Inc., Athera Biotechnologies AB, Biolight International AB, Affärsstrategerna AB, Samba Sensors AB, and SwedenBIO Service AB.
Akbar Seddigh active positions
| Companies | Position | Start |
|---|---|---|
| Blekinge Tekniska Högskola | Chairman | 2010-05-04 |
Former positions of Akbar Seddigh
| Companies | Position | End |
|---|---|---|
| ELEKTA AB | Chairman | 2013-09-02 |
Innovationsbron AB
 Innovationsbron AB Investment ManagersFinance Innovationsbron AB, established in 2005, is an agency set up and majority-owned by the Government of Sweden. Claes de Neergaard was mandated by the Ministry of Industry to develop innovative financing to commercially develop research-related business ideas. Headquartered in Stockholm, Innovationsbron also has four regional offices in Umea, Uppsala, Gothenburg and Lund. Innovationsbron operates a nationwide network of business incubators as well as a regional program of incubators which support scientists, innovators and entrepreneurs. | Chairman | 2012-12-30 |
| Biolight International AB | Director/Board Member | 2010-03-21 |
Athera Biotechnologies AB
 Athera Biotechnologies AB Pharmaceuticals: MajorHealth Technology Athera Biotechnologies AB operates as a biopharmaceutical company which focuses on developing targeted anti-inflammatory biological candidate drugs and companion diagnostics. It has a proprietary program the fully human antibody PC-mAb. The frim develops a biomarker and companion diagnostic CVDefine® kit. Its PC-mAb is a fully human monoclonal antibody which neutralizes a key driver of vascular inflammation, phosphorylcholine, which targets market of reducing secondary cardiovascular events, focusing on high-risk patients with low anti-PC levels. The company was founded by Johan Frostegard in 2002 and is headquartered in Stockholm, Sweden. | Director/Board Member | - |
A+ Science Holding AB
 A+ Science Holding AB MiscellaneousMiscellaneous A+ Science Holding AB operates as an investment company, which operates in the field of medical and biotechnology sector. It invests in the life science sector and especially in human medicine. The company was founded in 1997 and is headquartered in Göteborg, Sweden. | Chairman | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ELEKTA AB | Health Technology |
| Private companies | 9 |
|---|---|
Hedson Technologies International AB
 Hedson Technologies International AB Industrial MachineryProducer Manufacturing Hedson Technologies International AB sells equipment and supplies for the car and tires, through its subsidiary. It engages in the manufacture and trade of cleaning, drying, and lifting equipment for the automotive industry. The company was founded on August 26, 1992 and is headquartered in Arlöv, Sweden. | Producer Manufacturing |
Innovationsbron AB
Innovationsbron AB Investment ManagersFinance Innovationsbron AB, established in 2005, is an agency set up and majority-owned by the Government of Sweden. Claes de Neergaard was mandated by the Ministry of Industry to develop innovative financing to commercially develop research-related business ideas. Headquartered in Stockholm, Innovationsbron also has four regional offices in Umea, Uppsala, Gothenburg and Lund. Innovationsbron operates a nationwide network of business incubators as well as a regional program of incubators which support scientists, innovators and entrepreneurs. | Finance |
Samba Sensors AB
 Samba Sensors AB Electronic Equipment/InstrumentsElectronic Technology Samba Sensors AB is a developer and manufacturer of advanced fiber-optic pressure transducers for measurements of blood, intracranial, intradiscal, tissue, urological, and respiratory pressure. The company was founded by Olof Engström in 1991 and is headquartered in Gothenburg, Sweden. | Electronic Technology |
Light Sciences Oncology, Inc.
 Light Sciences Oncology, Inc. Pharmaceuticals: MajorHealth Technology Light Sciences Oncology, Inc. operates as a pharmaceutical company. It develops Aptocine for the treatment of solid tumors as well as other indications such as benign prostatic hyperplasia. The company was founded in 1994 and is headquartered in Bellevue, WA. | Health Technology |
Affärsstrategerna AB
 Affärsstrategerna AB Financial ConglomeratesFinance Affärsstrategerna AB is a venture capital company that invests in projects and companies that are in early stages. The firm invests in life science, information technology, wireless and energy sectors. Affärsstrategerna was founded in 1988 by Claes-Göran Fridh and is headquartered in Stockholm, Sweden. | Finance |
SwedenBIO Service AB
 SwedenBIO Service AB Miscellaneous Commercial ServicesCommercial Services SwedenBIO Service AB is a non-profit company that develops biotechnology, diagnostics, pharmaceuticals, and medical technology. It also offers counseling, education, opinion formation, and investigations. The company was founded in 2002 and is headquartered in Stockholm, Sweden. | Commercial Services |
| Biolight International AB | Health Technology |
A+ Science Holding AB
A+ Science Holding AB MiscellaneousMiscellaneous A+ Science Holding AB operates as an investment company, which operates in the field of medical and biotechnology sector. It invests in the life science sector and especially in human medicine. The company was founded in 1997 and is headquartered in Göteborg, Sweden. | Miscellaneous |
Athera Biotechnologies AB
Athera Biotechnologies AB Pharmaceuticals: MajorHealth Technology Athera Biotechnologies AB operates as a biopharmaceutical company which focuses on developing targeted anti-inflammatory biological candidate drugs and companion diagnostics. It has a proprietary program the fully human antibody PC-mAb. The frim develops a biomarker and companion diagnostic CVDefine® kit. Its PC-mAb is a fully human monoclonal antibody which neutralizes a key driver of vascular inflammation, phosphorylcholine, which targets market of reducing secondary cardiovascular events, focusing on high-risk patients with low anti-PC levels. The company was founded by Johan Frostegard in 2002 and is headquartered in Stockholm, Sweden. | Health Technology |
- Stock Market
- Insiders
- Akbar Seddigh
